| Literature DB >> 33819961 |
Hui Jie Hu1, Zhen Wei Zhang2, Yu Liang3, Yan Yan Luo1, Qi Feng Dou3, Cui Ping Song3, Hui Min Zhang1, Ying Zhao1, Guang Run Tian3, Ke Zhang3, Qiu Fang Mao2, Jing Gui Song4, Soren Rittig5, Jian Guo Wen3,4,6.
Abstract
PURPOSE: This study aimed to investigate the prevalence, risk factors, and effects of primary nocturnal enuresis (PNE) on physical and mental health in young adults in mainland China.Entities:
Keywords: Mental health; Prevalence; Primary nocturnal enuresis; Risk factors; Young adults
Year: 2021 PMID: 33819961 PMCID: PMC8022166 DOI: 10.5213/inj.2040398.149
Source DB: PubMed Journal: Int Neurourol J ISSN: 2093-4777 Impact factor: 2.835
Comparison of prevalence rates in different age groups
| Age (yr) | Male | Female | Total | χ2 | P-value | |||
|---|---|---|---|---|---|---|---|---|
| No. | PNE | No. | PNE | No. | PNE | |||
| 17 | 1,293 | 14 (1.08) | 2,591 | 27 (1.04) | 3,884 | 41 (1.06) | 0.01 | 0.91 |
| 18 | 2,017 | 32 (1.59) | 3,772 | 42 (1.11) | 5,789 | 74 (1.28) | 2.33 | 0.13 |
| 19 | 1,765 | 22 (1.25) | 3,285 | 34 (1.04) | 5,050 | 56 (1.11) | 0.47 | 0.49 |
| 20 | 733 | 10 (1.36) | 1,893 | 24 (1.27) | 2,626 | 34 (1.29) | 0.04 | 0.85 |
| 21 | 775 | 10 (1.29) | 2,221 | 24 (1.08) | 2,996 | 34 (1.13) | 0.25 | 0.62 |
| Total | 6,583 | 88 (1.34) | 13,762 | 151 (1.10) | 20,345 | 239 (1.17) | 2.20 | 0.13 |
Values are presented as number (%).
PNE, primary nocturnal enuresis.
The prevalence and risk factors for PNE in young adults
| Risk factor | No. | PNE | χ2 | P-value | |
|---|---|---|---|---|---|
| Yes | No | ||||
| Sex | |||||
| Male | 6,583 | 88 (1.3) | 6,495 (98.7) | 2.20 | 0.13 |
| Female | 13,762 | 151 (1.1) | 9,022 (98.9) | ||
| Place of residence | |||||
| Urban | 7,247 | 79 (1.0) | 7,168 (99.0) | 0.694 | 0.405 |
| Rural | 13,098 | 160 (1.2) | 12,938 (98.8) | ||
| Family history | |||||
| Yes | 637 | 81 (12.7) | 565 (87.3) | 742.54 | < 0.001 |
| No | 19,708 | 158 (0.8) | 19,550 (99.2) | ||
| Past history of UTI | |||||
| Yes | 1,365 | 71 (5.2) | 1,294 (94.8) | 202.71 | < 0.001 |
| No | 18,870 | 168 (0.9) | 18,702 (99.1) | ||
| Current UTI | |||||
| Yes | 921 | 70 (7.6) | 851 (82.4) | 343.09 | < 0.001 |
| No | 19,424 | 169 (0.9) | 19,255 (99.1) | ||
| Frequency | |||||
| Yes | 3,171 | 111 (3.5) | 3,060 (96.4) | 175.02 | < 0.001 |
| No | 17,174 | 128 (0.8) | 17,046 (99.2) | ||
| Urgency | |||||
| Yes | 4,833 | 116 (2.4) | 4,717 (97.6) | 81.993 | < 0.001 |
| No | 15,512 | 123 (0.8) | 15,389 (99.2) | ||
| UI | |||||
| Yes | 2,290 | 126 (5.5) | 2,164 (94.5) | 413.08 | < 0.001 |
| No | 17,945 | 113 (0.6) | 17,832 (99.4) | ||
Values are presented as number (%).
PNE, primary nocturnal enuresis; UTI, urinary tract infection; UI, urinary incontinence.
Logistic regression analysis of risk factors of PNE prevalence
| Risk factor | SE | P-value | OR | 95% CI | |
|---|---|---|---|---|---|
| Family history | 1.618 | 0.271 | < 0.001 | 5.043 | 2.962-8.586 |
| Past history of UTI | 0.901 | 0.336 | 0.007 | 2.462 | 1.275-4.754 |
| Current UTI | 1.983 | 0.305 | < 0.001 | 7.261 | 3.996-13.196 |
| Frequency | 0.636 | 0.174 | < 0.001 | 1.889 | 1.344-2.655 |
| Urgency | 0.506 | 0.168 | 0.003 | 1.658 | 1.194-2.304 |
| UI | 1.824 | 0.168 | < 0.001 | 6.198 | 4.460-8.613 |
PNE, primary nocturnal enuresis; UTI, urinary tract infection; UI, urinary incontinence; OR, odds ratio; CI, confidence interval.
SES and SDS scores between the PNE and non-PNE groups
| Score | Sex | PNE | P-value | ||
|---|---|---|---|---|---|
| Yes | No | ||||
| SES | Male | 27.03 ± 6.04 | 29.34 ± 5.59 | 2.79 | 0.005 |
| Female | 27.21 ± 3.02 | 29.54 ± 4.10 | 2.12 | 0.034 | |
| Total | 27.02 ± 5.36 | 29.37 ± 4.96 | 3.48 | < 0.001 | |
| SDS | Male | 53.09 ± 13.30 | 45.42 ± 12.57 | -3.79 | < 0.001 |
| Female | 56.43 ± 6.81 | 47.61 ± 9.34 | -3.52 | < 0.001 | |
| Total | 53.25 ± 11.74 | 45.62 ± 11.27 | -4.98 | < 0.001 | |
Values are presented as mean±standard deviation.
PNE, primary nocturnal enuresis; SES, Self-Esteem Scale; SDS, Self-Rating Depression Scale.
Higher scores indicate higher self-esteem and greater depression.
The effects of PNE on sleep quality
| PSQI score | Male | Female | Total | |||
|---|---|---|---|---|---|---|
| r | P-value | r | P-value | r | P-value | |
| C1 (sleep quality) | 0.080[ | 0.005 | 0.01 | 0.005 | 0.026 | 0.001 |
| C2 (sleep latency) | 0.009 | 0.742 | 0.020 | 0.341 | 0.017 | 0.288 |
| C3 (sleep duration) | 0.043 | 0.130 | 0.011 | 0.594 | 0.031 | 0.057 |
| C4 (sleep efficiency) | 0.000 | 0.993 | 0.00 | 0.815 | 0.003 | 0.871 |
| C5 (sleep disturbance) | 0.271[ | 0.019 | 0.330[ | 0.013 | 0.341[ | 0.000 |
| C6 (sleep medication use) | 0.126[ | 0.000 | 0.089[ | 0.000 | 0.119[ | 0.000 |
| C7 (daytime dysfunction) | 0.093[ | 0.001 | 0.086 | 0.003 | 0.035[ | 0.034 |
| Total score | 0.098[ | 0.001 | 0.067 | 0.009 | 0.041[ | 0.011 |
PNE, primary nocturnal enuresis; PSQI, Pittsburgh Sleep Quality Index.
‘r’ corresponds to Pearson correlation coefficients.
Correlation is significant at the 0.05 level (2-tailed).
Correlation is significant at the 0.01 level (2-tailed).
Differences in PSQI, SES, and SDS between the MNE and NMNE groups
| Total score | MNE (n=157) | NMNE (n=82) | P-value | |
|---|---|---|---|---|
| SES | 29.60 ± 4.21 | 27.42 ± 3.23 | 1.699 | 0.008 |
| SDS | 47.24 ± 9.87 | 52.77 ± 8.02 | 1.515 | 0.038 |
| PSQI | 4.23 ± 2.03 | 4.45 ± 2.57 | 1.603 | 0.012 |
Values are presented as mean±standard deviation.
PSQI, Pittsburgh Sleep Quality Index; SES, Self-Esteem Scale; SDS, Self-Rating Depression Scale; MNE, monosymptomatic nocturnal enuresis; NMNE, nonmonosymptomatic nocturnal enuresis.
Higher scores indicate higher self-esteem, greater depression, and poor sleep quality.